From the group archive · This article reflects its original publication date. For current information, see our latest publications and official disclosures.
May 27 (Reuters) – Nexgram Holdings Bhd:
* UNIT ENTERED SALES AGREEMENT WITH SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO
* AGREEMENT TO SELL DIAGNOSTIC KIT FOR ANTIBODY IGM/IGG OF COVID-19 IN MALAYSIA & INDONESIA
* AGREEMENT EXPECTED TO CONTRIBUTE POSITIVELY TO EARNINGS OF NEXGRAM GROUP DURING TENURE OF APPOINTMENT Source text:bit.ly/2ZJ0mlg Further company coverage: (Reuters.Briefs@thomsonreuters.com)